Metastases or benign adrenal lesions in patients with histopathological verification of lung cancer: Can CT texture analysis distinguish?
- PMID: 33798933
- DOI: 10.1016/j.ejrad.2021.109664
Metastases or benign adrenal lesions in patients with histopathological verification of lung cancer: Can CT texture analysis distinguish?
Abstract
Introduction: Distant metastases are found in the many of patients with lung cancer at time of diagnosis. Several diagnostic tools are available to distinguish between metastatic spread and benign lesions in the adrenal gland. However, all require additional diagnostic steps after the initial CT. The purpose of this study was to evaluate if texture analysis of CT-abnormal adrenal glands on the initial CT correctly differentiates between malignant and benign lesions in patients with confirmed lung cancer.
Materials and methods: In this retrospective study 160 patients with endoscopic ultrasound-guided biopsy from the left adrenal gland and a contrast-enhanced CT in portal venous phase were assessed with texture analysis. A region of interest encircling the entire adrenal gland was used and from this dataset the slice with the largest cross section of the lesion was analyzed individually.
Results: Several texture parameters showed statistically significantly difference between metastatic and benign lesions but with considerable between-groups overlaps in confidence intervals. Sensitivity and specificity were assessed using ROC-curves, and in univariate binary logistic regression the area under the curve ranged from 36 % (Kurtosis 0.5) to 69 % (Entropy 2.5) compared to 73 % in the best fitting model using multivariate binary logistic regression.
Conclusion: In lung cancer patients with abnormal adrenal gland at imaging, adrenal gland texture analyses appear not to have any role in discriminating benign from malignant lesions.
Keywords: Adrenal gland; Computed tomography; Lung cancer; Texture analysis.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Texture Analysis as a Radiomic Marker for Differentiating Benign From Malignant Adrenal Tumors.J Comput Assist Tomogr. 2020 Sep/Oct;44(5):766-771. doi: 10.1097/RCT.0000000000001051. J Comput Assist Tomogr. 2020. PMID: 32842071
-
Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI?AJR Am J Roentgenol. 2019 Mar;212(3):554-561. doi: 10.2214/AJR.18.20097. Epub 2019 Jan 8. AJR Am J Roentgenol. 2019. PMID: 30620676
-
The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.Nucl Med Commun. 2011 Feb;32(2):106-12. doi: 10.1097/MNM.0b013e32834199e7. Nucl Med Commun. 2011. PMID: 21085046
-
The role of percutaneous CT-guided biopsy of an adrenal lesion in patients with known or suspected lung cancer.Abdom Radiol (NY). 2021 Mar;46(3):1171-1178. doi: 10.1007/s00261-020-02743-9. Epub 2020 Sep 18. Abdom Radiol (NY). 2021. PMID: 32945923
-
Hyperattenuating adrenal lesions in lung cancer: biphasic CT with unenhanced and 1-min enhanced images reliably predicts benign lesions.Eur Radiol. 2021 Aug;31(8):5948-5958. doi: 10.1007/s00330-020-07648-1. Epub 2021 Jan 18. Eur Radiol. 2021. PMID: 33459853
Cited by
-
Adrenal Mass Evaluation: Suspicious Radiological Signs of Malignancy.Cancers (Basel). 2025 Feb 28;17(5):849. doi: 10.3390/cancers17050849. Cancers (Basel). 2025. PMID: 40075696 Free PMC article. Review.
-
Deep learning vs. robust federal learning for distinguishing adrenal metastases from benign lesions with multi-phase CT images.Heliyon. 2024 Feb 6;10(3):e25655. doi: 10.1016/j.heliyon.2024.e25655. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38371957 Free PMC article.
-
Diagnostic Accuracy of CT Texture Analysis in Adrenal Masses: A Systematic Review.Int J Mol Sci. 2022 Jan 7;23(2):637. doi: 10.3390/ijms23020637. Int J Mol Sci. 2022. PMID: 35054823 Free PMC article.
-
Radiomics approach based on biphasic CT images well differentiate "early stage" of adrenal metastases from lipid-poor adenomas: A STARD compliant article.Medicine (Baltimore). 2022 Sep 23;101(38):e30856. doi: 10.1097/MD.0000000000030856. Medicine (Baltimore). 2022. PMID: 36197274 Free PMC article.
-
A modified method for CT radiomics region-of-interest segmentation in adrenal lipid-poor adenomas: a two-institution comparative study.Front Oncol. 2023 Apr 19;13:1086039. doi: 10.3389/fonc.2023.1086039. eCollection 2023. Front Oncol. 2023. PMID: 37152026 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical